Breaking News19 November

Every day, thousands of trained K9 dogs sniff out narcotics, explosives and missing people. These dogs are invaluable for security, but they're also expensive. Duke researchers have made the beginning steps toward an artificial 'robot nose' device that officers could use instead of dogs. The heart of the system would be living odor receptors grown from mouse genes that respond to target odors, including the smells of cocaine and explosives.

Researchers in the School of Engineering & Applied Science have discovered a new, natural law that sheds light on the fundamental relationship between coated black carbon and light absorption.

In a study published in the journal NPJ Breast Cancer, researchers reported they used a form of artificial intelligence called machine learning, or deep learning, to train a computer to identify certain features of breast cancer tumors from images.

New University of Kent-led research on the way a common gut parasite behaves could help lead to a better understanding of its role in the development of intestinal diseases such as irritable bowel syndrome.

Forget those shepherding moons. Gravity and the odd shapes of asteroid Chariklo and dwarf planet Haumea -- small objects deep in our solar system -- can be credited for forming and maintaining their own rings, according new research in Nature Astronomy.

In-person social contact seems to offer some protection against depression and PTSD symptoms, but the same is not true of contact on Facebook, suggests a study by Veterans Affairs researchers and colleagues.

Controlled ingestion of peanut protein could help build tolerance in peanut allergy sufferers. Authors of a new study published in the New England Journal of Medicine say an oral immunotherapy drug they tested could be the first FDA-approved medication of its kind for people with peanut allergy. The medication, called AR101, is derived from peanut protein.